The high prevalence of GSTP1 hypermethylation in prostate cancer, HGPIN and in some proliferative inflammatory atrophy lesions indicates that it most likely precedes many other molecular aberrations in prostate carcinogenesis (Nakayama et al, 2003). The gene discussed is GSTP1; the disease is Familial prostate cancer.